The Wall Street Journal reported Friday that Bausch & Lomb Inc. is nearing a deal to sell itself to Valeant Pharmaceuticals International (VRX) for about $9 billion.
Valeant spiked sharply to the upside midday Friday and finished higher by 9.80 at $84.47, with volume at over an 8-month high. The stock surged past resistance and set a new high for the year.
For comments and feedback: editorial@rttnews.com